Last 25 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.73 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.29 | 1.51 | 1.43 | 0.46 | 0.63 | 2.12 | 1.95 | 2.50 | 1.69 | 2.00 | 2.32 | 3.94 | 3.16 | 4.95 | 9.36 | 8.76 | 6.42 | 9.25 | 6.62 | 8.92 | 7.47 |
| — | -29.0% | -27.0% | -81.7% | -62.9% | +6.0% | -15.8% | -36.6% | -46.6% | -59.6% | -75.2% | -55.0% | -50.7% | -46.5% | +41.4% | -1.8% | -14.1% | -43.6% | -64.4% | — | — | |
| P/B Ratio | 2.92 | 4.72 | 3.82 | 1.12 | 1.79 | 4.78 | 3.80 | 4.99 | 4.11 | 3.44 | 3.68 | 6.38 | 5.70 | 5.85 | 10.47 | 9.39 | 21.10 | 19.67 | 11.06 | 11.94 | 10.74 |
| — | -1.3% | +0.7% | -77.5% | -56.4% | +38.9% | +3.1% | -21.8% | -28.0% | -41.2% | -64.8% | -32.0% | -73.0% | -70.2% | -5.3% | -21.4% | +96.5% | +34.9% | -26.0% | — | — | |
| P/FCF | — | — | — | 5.19 | — | — | — | 200.66 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | -97.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 64.21 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | 160.55 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.8% | 79.5% | 78.5% | 79.3% | 80.6% | 79.1% | 79.7% | 79.7% | 80.7% | 80.1% | 80.2% | 80.2% | 81.6% | 80.4% | 81.7% | 80.9% | 80.4% | 81.6% | 82.3% | 82.3% | 81.1% |
| — | +0.5% | -1.5% | -0.5% | -0.2% | -1.3% | -0.7% | -0.6% | -1.0% | -0.3% | -1.8% | -0.9% | +1.4% | -1.5% | -0.8% | -1.7% | -0.9% | +1.5% | +1.8% | +0.2% | +2.8% | |
| Operating Margin | -25.5% | -23.9% | -33.0% | -36.4% | -9.5% | -31.2% | -35.8% | -29.6% | -0.3% | -33.6% | -48.1% | -37.1% | -10.9% | -43.7% | -31.1% | -32.6% | -7.0% | -34.2% | -39.8% | -27.9% | -16.7% |
| — | +23.4% | +8.0% | -22.7% | -3090.4% | +7.0% | +25.5% | +20.1% | +97.3% | +23.2% | -54.6% | -13.7% | -55.1% | -27.7% | +21.9% | -17.1% | +58.0% | -35.6% | -103.0% | -271.9% | -211.0% | |
| Net Margin | -27.7% | -26.0% | -35.0% | -38.1% | -15.0% | -32.4% | -36.7% | -30.3% | -0.7% | -34.1% | -47.7% | -36.5% | -10.1% | -43.0% | -29.2% | -31.9% | -8.9% | -36.7% | -57.5% | -31.1% | -19.8% |
| — | +19.7% | +4.7% | -25.6% | -1960.6% | +4.8% | +23.0% | +17.1% | +92.8% | +20.7% | -63.1% | -14.6% | -13.9% | -17.1% | +49.1% | -2.5% | +55.2% | -23.6% | -133.7% | -139.3% | -285.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -58.9% | -19.4% | -21.9% | -21.8% | -10.6% | -17.4% | -17.1% | -14.6% | -0.5% | -14.2% | -17.8% | -14.1% | -4.6% | -12.2% | -8.0% | -12.3% | -7.2% | -18.1% | -21.7% | -10.0% | -7.0% |
| — | -11.4% | -27.8% | -49.6% | -2213.3% | -23.2% | +3.6% | -3.3% | +89.9% | -16.3% | -122.8% | -14.6% | +36.6% | +32.8% | +63.3% | -22.8% | -3.4% | -182.7% | -118.6% | +99.8% | -105.3% | |
| ROA | -28.9% | -7.0% | -8.7% | -9.6% | -4.9% | -8.1% | -8.4% | -7.5% | -0.2% | -7.0% | -9.0% | -7.6% | -2.6% | -7.2% | -4.9% | -6.6% | -2.8% | -7.7% | -11.3% | -6.3% | -4.8% |
| — | +13.7% | -3.0% | -27.3% | -1982.7% | -15.5% | +6.7% | +0.3% | +90.9% | +2.2% | -83.9% | -14.6% | +8.8% | +7.1% | +56.4% | -4.8% | +41.2% | -67.9% | -99.6% | -2.4% | -177.4% | |
| ROIC | -31.0% | -8.9% | -10.7% | -15.0% | -3.7% | -7.5% | -7.9% | -7.0% | -0.1% | -6.9% | -9.1% | -7.4% | -2.6% | -6.5% | -4.8% | -6.7% | -3.4% | -19.6% | -24.2% | -24.5% | -24.8% |
| — | -17.9% | -35.3% | -113.2% | -3899.3% | -8.6% | +13.2% | +5.5% | +96.4% | -6.2% | -89.0% | -10.5% | +24.0% | +66.6% | +80.0% | +72.5% | +86.4% | +28.6% | +0.8% | -202.7% | -231.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.16 | 0.20 | 1.07 | 0.18 | 0.16 | 0.79 | 0.72 | 0.66 | 0.62 | 0.67 | 0.62 | 0.55 | 0.51 | 0.51 | 0.46 | 0.44 | 1.13 | 1.16 | 0.99 | 0.51 | 0.32 |
| — | -74.1% | +49.4% | -73.3% | -74.1% | +18.0% | +15.3% | +18.7% | +21.1% | +30.7% | +34.2% | +26.2% | -55.0% | -55.8% | -52.9% | -14.6% | +259.2% | +284.4% | +246.8% | — | -99.2% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 34.26 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.31 | 2.58 | 2.90 | 3.58 | 4.31 | 3.37 | 3.52 | 4.50 | 4.62 | 4.12 | 3.86 | 3.98 | 4.40 | 5.64 | 6.60 | 9.58 | 4.41 | 5.66 | 8.13 | 8.28 | 7.58 |
| — | -23.6% | -17.6% | -20.5% | -6.7% | -18.1% | -8.7% | +13.1% | +4.9% | -27.0% | -41.5% | -58.4% | -0.1% | -0.3% | -18.8% | +15.7% | -41.8% | -55.1% | -43.1% | +95.1% | +114.4% | |
| Quick Ratio | 3.13 | 1.66 | 1.95 | 2.53 | 3.13 | 2.36 | 2.51 | 3.36 | 3.50 | 2.98 | 2.93 | 3.22 | 3.76 | 4.76 | 5.73 | 8.61 | 3.77 | 4.92 | 7.33 | 7.56 | 7.00 |
| — | -29.8% | -22.3% | -24.8% | -10.4% | -20.8% | -14.3% | +4.3% | -6.9% | -37.4% | -48.8% | -62.6% | -0.4% | -3.3% | -21.9% | +14.0% | -46.1% | -57.8% | -45.7% | +123.1% | +144.7% | |
| Interest Coverage | -10.09 | -7.28 | -9.16 | -10.44 | -5.96 | -11.17 | -12.17 | -11.14 | 0.62 | -10.70 | -15.16 | -13.18 | -3.82 | -12.52 | -8.57 | -9.47 | -2.37 | -9.20 | -17.22 | -8.50 | -5.44 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 25 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TMCI stock.
Treace Medical Concepts, Inc.'s current P/E is -4.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Treace Medical Concepts, Inc.'s current operating margin is -25.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Treace Medical Concepts, Inc.'s business trajectory between earnings reports.